UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

ubiquitin landscape at DNA double-strand breaks

The Journal of cell biology, 2009-11, Vol.187 (3), p.319-326

2009

Link zum Volltext

Verfügbarkeit prüfen

EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein–Barr virus-associated gastric cancer

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2021-09, Vol.24 (5), p.1076-1088

2021

Link zum Volltext

Verfügbarkeit prüfen

The Natural Stilbenoid (–)-Hopeaphenol Inhibits Cellular Entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7, and B.1.351 Variants

Antimicrobial agents and chemotherapy, 2021-11, Vol.65 (12), p.e0077221-e0077221

2021

Link zum Volltext

Verfügbarkeit prüfen

Epigenetic Plasticity Enables CNS-Trafficking of EBV-infected B Lymphocytes

PLoS pathogens, 2021-06, Vol.17 (6), p.e1009618

2021

Link zum Volltext

Verfügbarkeit prüfen

MERIT40 controls BRCA1-Rap80 complex integrity and recruitment to DNA double-strand breaks

Genes & development, 2009-03, Vol.23 (6), p.740-754

2009

Link zum Volltext

Verfügbarkeit prüfen

Biophysical Screens Identify Fragments That Bind to the Viral DNA-Binding Proteins EBNA1 and LANA

Molecules (Basel, Switzerland), 2020-04, Vol.25 (7), p.1760

2020

Link zum Volltext

Verfügbarkeit prüfen

Differential Regulation of JAMM Domain Deubiquitinating Enzyme Activity within the RAP80 Complex

The Journal of biological chemistry, 2010-10, Vol.285 (40), p.30971-30981

2010

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of pro-HGF activation by SRI31215, a novel approach to block oncogenic HGF/MET signaling

Oncotarget, 2016-05, Vol.7 (20), p.29492-29506

2016

Link zum Volltext

Verfügbarkeit prüfen

Cell-cycle-dependent EBNA1-DNA crosslinking promotes replication termination at oriP and viral episome maintenance

Cell, 2021-02, Vol.184 (3), p.643-654.e13

2021

Link zum Volltext

Verfügbarkeit prüfen

Cryo-EM Structure and Functional Studies of EBNA1 Binding to the Family of Repeats and Dyad Symmetry Elements of Epstein-Barr Virus oriP

Journal of virology, 2022-09, Vol.96 (17), p.e0094922-e0094922

2022

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic approaches to Epstein–Barr virus cancers

Current opinion in virology, 2022-10, Vol.56, p.101260-101260, Article 101260

2022

Link zum Volltext

Verfügbarkeit prüfen

Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth

Science translational medicine, 2019-03, Vol.11 (482)

2019

Link zum Volltext

Verfügbarkeit prüfen

Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance

Journal of virology, 2017-10, Vol.91 (19)

2017

Link zum Volltext

Verfügbarkeit prüfen

Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication

Journal of virology, 2019-10, Vol.93 (20)

2019

Link zum Volltext

Verfügbarkeit prüfen

Computational analysis of EBNA1 “druggability” suggests novel insights for Epstein-Barr virus inhibitor design

Journal of computer-aided molecular design, 2016-04, Vol.30 (4), p.285-303

2016

Link zum Volltext

Verfügbarkeit prüfen

Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of VK‐2019, a selective EBNA1 inhibitor

Biomedical chromatography, 2024-02, Vol.38 (2), p.e5775-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

Metabolomic Analysis and Antiviral Screening of a Marine Algae Library Yield Jobosic Acid (2,5-Dimethyltetradecanoic Acid) as a Selective Inhibitor of SARS-CoV‑2

Journal of natural products (Washington, D.C.), 2024-06, Vol.87 (6), p.1513-1520

2024

Link zum Volltext

Verfügbarkeit prüfen

Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency

Oncotarget, 2017-01, Vol.8 (5), p.7248-7264

2017

Link zum Volltext

Verfügbarkeit prüfen

Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer

Cancer discovery, 2013-04, Vol.3 (4), p.399-405

2013

Link zum Volltext

Verfügbarkeit prüfen

Crystal structure and functional interpretation of the erythrocyte spectrin tetramerization domain complex

Blood, 2010-06, Vol.115 (23), p.4843-4852

2010

Link zum Volltext

Verfügbarkeit prüfen

Disruption of host antiviral resistances by gammaherpesvirus tegument proteins with homology to the FGARAT purine biosynthesis enzyme

Current opinion in virology, 2015-10, Vol.14, p.30-40

2015

Link zum Volltext

Verfügbarkeit prüfen

Correction: Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency

Oncotarget, 2019-07, Vol.10 (43), p.4505-4506

2019

Link zum Volltext

Verfügbarkeit prüfen

EBNA1 Inhibitors Block Proliferation of Spontaneous Lymphoblastoid Cell Lines From Patients With Multiple Sclerosis and Healthy Controls

Neurology : neuroimmunology & neuroinflammation, 2023-09, Vol.10 (5)

2023

Link zum Volltext

Verfügbarkeit prüfen

Design and Synthesis of Nonpeptide Inhibitors of Hepatocyte Growth Factor Activation

ACS medicinal chemistry letters, 2016-02, Vol.7 (2), p.177-181

2016

Link zum Volltext

Verfügbarkeit prüfen

Cell Cycle-Dependent EBNA1-DNA Cross-Linking Promotes Replication Termination at oriP and Viral Episome Maintenance

Cell, 2021-01, Vol.184 (3), p.643-654.e13

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)
Japanisch
(6)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

ubiquitin landscape at DNA double-strand breaks

EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein–Barr virus-associated gastric cancer

The Natural Stilbenoid (–)-Hopeaphenol Inhibits Cellular Entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7, and B.1.351 Variants

Epigenetic Plasticity Enables CNS-Trafficking of EBV-infected B Lymphocytes

MERIT40 controls BRCA1-Rap80 complex integrity and recruitment to DNA double-strand breaks

Biophysical Screens Identify Fragments That Bind to the Viral DNA-Binding Proteins EBNA1 and LANA

Differential Regulation of JAMM Domain Deubiquitinating Enzyme Activity within the RAP80 Complex

Inhibition of pro-HGF activation by SRI31215, a novel approach to block oncogenic HGF/MET signaling

Cell-cycle-dependent EBNA1-DNA crosslinking promotes replication termination at oriP and viral episome maintenance

Cryo-EM Structure and Functional Studies of EBNA1 Binding to the Family of Repeats and Dyad Symmetry Elements of Epstein-Barr Virus oriP

Therapeutic approaches to Epstein–Barr virus cancers

Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth

Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance

Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication

Computational analysis of EBNA1 “druggability” suggests novel insights for Epstein-Barr virus inhibitor design

Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of VK‐2019, a selective EBNA1 inhibitor

Metabolomic Analysis and Antiviral Screening of a Marine Algae Library Yield Jobosic Acid (2,5-Dimethyltetradecanoic Acid) as a Selective Inhibitor of SARS-CoV‑2

Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency

Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer

Crystal structure and functional interpretation of the erythrocyte spectrin tetramerization domain complex

Disruption of host antiviral resistances by gammaherpesvirus tegument proteins with homology to the FGARAT purine biosynthesis enzyme

Correction: Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency

EBNA1 Inhibitors Block Proliferation of Spontaneous Lymphoblastoid Cell Lines From Patients With Multiple Sclerosis and Healthy Controls

Design and Synthesis of Nonpeptide Inhibitors of Hepatocyte Growth Factor Activation

Cell Cycle-Dependent EBNA1-DNA Cross-Linking Promotes Replication Termination at oriP and Viral Episome Maintenance

Suchergebnisse filtern